Melissa Easy and Tim Riely of IQVIA talk about the current state of AI in life sciences and clinical trials. They discuss overcoming challenges in clinical trials during the pandemic with the help of AI technologies. They also highlight the challenges of applying AI in clinical trials and explore ways to reduce patient burden and design effective trials. The impact of AI-enhanced clinical trials on patient experiences is discussed, emphasizing the need for easy patient journeys and diversity in representation.